National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$47.00
add to cart

Rights & Permissions

topleft topright

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (2010)
Board on Health Care Services (HCS)
Board on Health Sciences Policy (HSP)
Food and Nutrition Board (FNB)

Citation Manager

. "Appendix C: Committee Member and Consultant Biographies." Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, DC: The National Academies Press, 2010.

Please select a format:

BibTeX EndNote RefMan


Page
288
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

cine internship, residency, and chief residency at Columbia University Presbyterian Medical Center. She then completed a clinical and research fellowship in Cardiovascular Diseases at the Brigham and Women’s Hospital. Dr. Albert also completed a research fellowship in Cardiovascular Epidemiology at that hospital and, during that time, earned an M.P.H. with a concentration in Epidemiology from the Harvard School of Public Health.

Dr. Albert devotes approximately 3 months of the year to clinical duties and 8 months to research activities. Specifically, she is an attending physician for the clinical cardiovascular services and cardiac intensive care units at Brigham and Women’s Hospital. In these roles, her clinical responsibilities include care for the most critically ill cardiovascular patients. Dr. Albert’s research interest concerns the molecular and genetic epidemiology of hemostasis, thrombosis, and inflammation. A central component of her work involves cardiovascular risk prediction using novel biochemical markers in large population-based cohorts. Specifically, Dr. Albert is involved in comparative cardiovascular risk assessment in different race/ethnic groups and international populations as well as work related to the role of chronic psychological stress on cardiovascular outcome. As the Principal Investigator (PI) of a Doris Duke Clinical Scientist Development Award, she piloted a blood collection project to evaluate novel biochemical markers and genetic polymorphisms of cardiovascular risk among geographically diverse Black women living in the United States. Funding from the Donald W. Reynolds Foundation as an Associate Investigator also supports this work. Her research time encompasses developing clinical and epidemiologic cohorts, devising clinical hypotheses, performing data analyses, writing manuscripts, and presenting her findings at numerous venues.

Dr. Albert also teaches Harvard Medical School students and residents at the Veterans Administration (VA) Medical Center and Brigham and Women’s Hospital. Dr. Albert is actively involved in several professional organizations, including the Association of Black Cardiologists, American Heart Association (AHA), and the American College of Cardiology (ACC).


Fred Apple, Ph.D., is a professor in the Department of Laboratory Medicine and Pathology at the University of Minnesota–Twin Cities. He also serves as the medical director of Clinical Laboratories and the Clinical Chemistry and Toxicology Laboratories at Hennepin County Medical Center. In addition, he serves as the forensic toxicology consultant to the Hennepin County Medical Examiner’s Office. Dr. Apple instructs residents and Fellows during their Chemistry and Toxicology rotations, and directs the Ph.D. Clinical Chemistry Fellowship program. Dr. Apple’s

Page
288